Memorial Sloan Kettering Cancer Center

History

Early history of Memorial Hospital (1884–1934)

The hospital was founded in its original building on the Upper West Side of Manhattan The hospital appointed as an attending surgeon William B. Coley, who pioneered an early form of immunotherapy to eradicate tumors. Rose Hawthorne, daughter of author Nathaniel Hawthorne, trained there in the summer of 1896 before founding her own order, Dominican Sisters of Hawthorne. In 1899, the hospital was renamed General Memorial Hospital for the Treatment of Cancer and Allied Diseases. In 1902, Arabella Huntington made a (equivalent to $million in ) bequest in memory of her late husband Collis Potter Huntington to establish the first cancer research fund in the country, the Huntington Fund for Cancer Research.

Around 1910, James Ewing, a professor at Cornell University's medical college, established a collaboration with Memorial Hospital with the help and funding of industrialist and philanthropist James Douglas, who gave $100,000 (equivalent to $million in ) to endow twenty beds for clinical research, equipment for working with radium, and a clinical laboratory for that purpose.

The first fellowship training program in the U.S. was created at Memorial in 1927, funded by the Rockefellers. In 1931 the then-most-powerful 900k-volt X-ray tube was put into use in radiation-based cancer treatment at Memorial; the tube had been built by General Electric over several years. In 1931 Ewing was formally appointed president of the hospital, a role he had effectively played until then, the accompanying article described his role as one of the most important cancer doctors of his era. He worked at the Memorial until his retirement, in 1939. Under his leadership, Memorial became a model for other cancer centers in the United States, combining patient care with clinical and laboratory research,

Memorial Hospital and the Sloan Kettering Institute (1934–1980)

In 1934, John D. Rockefeller Jr. donated land on York Avenue for a new location. Two years later, he granted Memorial Hospital for the Treatment of Cancer and Allied Diseases (Memorial Hospital) $3.0million (equivalent to $million in ) and the hospital began their move across town. Memorial Hospital officially reopened at the new location in 1939. In 1945, the chairman of General Motors, Alfred P. Sloan, donated $4.0million (equivalent to $million in ) to create the Sloan-Kettering Institute for Cancer Research through his Sloan Foundation, and Charles F. Kettering, GM's vice president and director of research, personally agreed to oversee the organization of a cancer research program based on industrial techniques. The originally independent research institute was built adjacent to Memorial Hospital.

In 1948, Cornelius P. Rhoads became the director of Memorial. Rhoads had run chemical weapons programs for the United States Army in World War II, and had been involved in the work that led to the discovery that nitrogen mustards could potentially be used as cancer drugs.

From the mid-1950s to the mid-1960s Chester M. Southam conducted pioneering clinical research on virotherapy and cancer immunotherapy at MSK; however he conducted his research on people without their informed consent. He did this to patients under his care or others' care, and to prisoners. In 1963 some doctors objected to the lack of consent in his experiments and reported him to the Regents of the University of the State of New York which found him guilty of fraud, deceit, and unprofessional conduct, and in the end, he was placed on probation for a year.

In 1960, Memorial Sloan Kettering Cancer Center was formed as a new corporation to coordinate the two institutions, and John Heller, the former director of the National Cancer Institute was named its president. At the end of the 1960s, as the field of pediatric oncology began seeing success in treating children with cancer, Memorial opened an outpatient pediatric day hospital, partly to deal with the growing number of cancer survivors.

In the early 1970s, Burchenal and Benno Schmidt, a professional investor and trustee of MSK, were appointed to the presidential panel that initiated the U.S. federal government's war on cancer in the early 1970s.

In 1977, Jimmie C. Holland established a full-time psychiatric service at MSK dedicated to helping people with cancer cope with their disease and its treatment; it was one of the first such programs and was part of the creation of the field of psycho-oncology.

Memorial Sloan Kettering Cancer Center (1980–present)

In 1980, Memorial Hospital and the Sloan-Kettering Institute formally merged into a singe entity under the name Memorial Sloan Kettering Cancer Center. In 1985, , Erich Platzer, Janice Gabrilove, Roland Mertelsmann and Malcolm Moore at the Memorial Sloan Kettering Cancer Center (MSK) purified human G-CSF.

In 1986, the center patented the method of producing and using human G-CSF under the name "human hematopoietic pluripotent colony stimulating factor" (P-CSF). Also in 1986, Shigekazu Nagata's team and Lawrence Souza's team at Amgen cloned the G-CSF gene for production and its clinical use.

In 1990 it entered an agreement with Amgen to receive royalties for the recombinant granulocyte colony-stimulating factor, the basis for neupogen and neulasta, earning the institute over $100 million.

In 2000, former NIH director Harold Varmus became director of MSK. During his tenure, he helped build new facilities, strengthened the bond between MSK's clinical and research arms, and fostered collaborations with other institutions, including Weill-Cornell Medical College and Rockefeller University.

In 2006, MSK opened the Mortimer B. Zuckerman Research Center, a 23-story building that houses over 100 laboratories. In 2009 it opened the Evelyn H. Lauder Breast Center.

In 2010, Craig B. Thompson, an oncologist and researcher, was appointed MSK's president and CEO. The following year, MSK was rated the third most successful nonprofit in terms of FDA-approved drugs and vaccines, behind the National Institutes of Health and the University of California system. In 2012, Thompson appointed José Baselga as physician-in-chief, who directed the clinical side of MSK. That same year, a collaboration with IBM's Watson was announced with the goal of developing new tools and resources to better tailor diagnostic and treatment recommendations for patients. The director of SKI, the research arm of MSK, Joan Massagué was appointed in 2013. Baselga resigned in September 2018 after information came out regarding millions of dollars he received from pharmaceutical companies without disclosing a financial conflict of interest.

In 2015 it opened the Josie Robertson Surgery Center for outpatient surgeries, named in honor of the wife of philanthropist Julian Robertson.

In 2017, the Food and Drug Administration approved an MSK-developed immunotherapy, CAR-T, for certain applications in leukemia and lymphoma. The FDA approved the first academic or commercial tumor identification test MSK-IMPACT in November 2018.

In 2020 it opened The David H. Koch Center for Cancer Care as an outpatient facility.

In April 2022, MSK announced a $50 million donation from The Starr Foundation to aid in expanding funding for basic cancer research and discovery science. The donation will establish The Starr Foundation programme for Discovery Science at the Sloan Kettering Institute, the goal of the institute is to drive next-generation cancer breakthroughs.

In June 2022, a small trial of an experimental treatment found that tumors vanished in all 14 patients diagnosed with early stage rectal cancer who completed the study by the time it was published.

In 2023 MSK received a donation of $400 million from David Geffen and Kenneth C. Griffin.

In 2025, cancer patient Jennifer Capasso sued MSK over remarks about her transgender identity while she was under sedation during a surgical procedure in 2022, and subsequent alleged discrimination by the hospital staff.

MSK has expanded into regional sites, including in Westchester County, New York, Commack, Hauppauge, Rockville Centre on Long Island, and Bergen County, Monmouth County, and Basking Ridge in New Jersey.

MSK currently employs over 1,200 physicians and treats patients with approximately 400 types of cancer annually.

Associated facilities and programs

The Memorial Sloan Kettering Bendheim Integrative Medicine Center is a stand alone outpatient facility developed from the Integrative Medicine Service that began in 1999.

The Center for Image-Guided Intervention was opened in June 2010 in the Memorial Hospital building to oversee image guiding activities across MSK. In October 2012, the Sillerman Center for Rehabilitation was opened, moving rehabilitation out of Memorial Hospital and closer to the Rockefeller Outpatient Pavilion.

The New York Proton Center opened in 2019 as a partnership between Memorial Sloan Kettering, Montefiore Health, and Mount Sinai Health System. The center was the first proton therapy center to open in New York state. The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center opened at 530 East 74th Street between York Avenue and FDR Drive January 2020. Perkins Eastman designed 750,000 sq ft facility in collaboration with Ennead Architects and ICRAVE. Thornton Tomasetti served as structural engineer, with Jaros, Baum & Bolles providing MEP engineering.

India Center

The center launched its India facility in Chennai in August 2022, to provide telemedicine services in collaboration with iCiliniq to facilitate second opinion from the cancer specialists, without the need to travel to a U.S. facility.

Training

Approximately 1,700 medical residents and Fellows are in training at MSK. There are 575 postdoctoral researchers training at MSK labs and a combined 288 PhD and MD-PhD candidates.

In 2004, the Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences was opened at Memorial Sloan Kettering Cancer Center. The first students graduated in 2012. As of January 2019, the dean of the graduate school is cell biologist Michael Overholtzer. The founding dean, serving for over a decade, was molecular biologist Ken Marians.

The Tri-Institutional MD–PhD Program is a partnership of MSKCC, Weill Cornell Medicine, and The Rockefeller University. The dual degree program takes advantage of the close proximity of these three institutions for collaboration on biomedical research and medical training. MSKCC also has an academic partnership with Weill Cornell Medicine known as the Weill Cornell Graduate School of Medical Sciences.

Notable faculty

Presidents

The following individuals have served as president, first of the overarching corporation (1960–1980), and later of the combined hospital (1980 onwards).

• John R. Heller, 1960–1961
• Richard D. Vanderwarker, 1962–1971
• David Walsh, 1971–1973
• Lewis Thomas, 1973–1980
• Paul A. Marks, 1980–1999
• Harold Varmus, 2000–2010
• Craig B. Thompson, 2010–2022
• Selwyn M. Vickers, 2022–

Presidents of the Memorial Hospital for Cancer and Allied Diseases

• John E. Parsons, 1884–1915
• Herbert Parsons, 1915–1917
• George C. Clark, 1917–1919
• Herbert Parsons, 1919–1923
• Walter Douglas, 1924–1932
• Harry P. Robbins, 1933–1944
• Reginald G. Coombe, 1945–1950
• Laurance Rockefeller, 1950–1958
• B. Brewster Jennings, 1958–1961
• Ogden White, 1962–1964
• John M. Walker, 1965–1973
• James D. Robinson III, 1974–1980

Presidents of the Sloan Kettering Institute

• Frank A. Howard, 1945–1959
• Frank L. Horsfall, 1960–1971
• Leo Wade, 1971–1972
• Robert A. Good, 1973–1980

Others

• James P. Allison
• Kathryn V. Anderson
• Esther Babady
• Edward Boyse
• Murray Brennan
• Carol L. Brown
• Samuel Danishefsky
• Nori Dattatreyudu
• Lisa DeAngelis
• Jeffrey Drebin
• Jimmie C. Holland
• Jerard Hurwitz
• Maria Jasin
• Alex Kentsis
• David Kissane
• Mathilde Krim
• Iris Long
• Scott W. Lowe
• Joan Massagué
• John Mendelsohn
• Kenneth Offit
• Lloyd Old
• Nikola P. Pavletich
• Mark S. Ptashne
• Ora Mendelsohn Rosen
• James Rothman
• Alexander Rudensky
• Valerie Rusch
• Michel Sadelain
• Charles Sawyers
• Lorenz Studer
• Doris L. Berryman

Reputation

In 2015, Charity Watch rated Memorial Sloan Kettering Cancer Center an "A". That same year, heads of the charity received $2,107,939 to $2,639,669 salary/compensation from the charity. CEO Craig B. Thompson received $2,554,085 salary/compensation from the charity.

References

References

1. "NYS Health Profiles: Memorial Hospital for Cancer and Allied Diseases".
2. "Memorial Sloan Kettering Cancer Center". Forbes.
3. (May 18, 1884). "The New York Cancer Hospital: laying the corner-stone of a much-needed institution". [[The New York Times]].
4. (5 April 2012). "NCI-Designated Cancer Centers". National Cancer Institute.
5. Abel, Emily K.. (2013). "The inevitable hour: a history of caring for dying patients in America". Johns Hopkins University Press.
6. (2014). "Coley to Cure:The Story of the Cancer Research Institute". Cancer Research Institute.
7. (2013). "Changing the Way We Die: Compassionate End of Life Care and The Hospice Movement". Cleis Press.
8. (February 16, 1899). "SESSION OF THE SENATE.; Bills Passed and Introduced and Routine Business Transacted.". [[The New York Times]].
9. "Memorial Hospital for the Treatment of Cancer and Allied Diseases Thirty First Annual Report for the Year 1915".
10. (February 25, 1970). "James Ewing Society, 1940-1969: Presidential Address". Cancer.
11. (March 1, 1931). "900,000-VOLT TUBE TO COMBAT CANCER: Largest X-Ray Device of Kind Being Built by General Electric for Hospital Here". The New York Times.
12. "Cancer Crusade". January 12, 1931. [[Time (magazine). ''Time'']] 17(2):26
13. (Mar 2012). "Biographical sketch: James Stephen Ewing, MD (1844-1943)". Clin Orthop Relat Res.
14. Murphy, James B.. (1951). "James Ewing—1866–1943". National Academy of Sciences.
15. (December 28, 1934). "Rockefeller Gives Block to Institute". The New York Times.
16. (1936-04-28). "Rockefeller Provides $3,000,000 to Build Cancer Hospital Here". [[The New York Times]].
17. (June 16, 1939). "THE MEMORIAL HOSPITAL". The New York Times.
18. Memorial Sloan Kettering Cancer Center. "History & Milestones. Memorial Sloan Kettering Cancer Center website.".
19. (August 8, 1945). "Sloan, Kettering to Combat Cancer; Studying Sketch of Proposed Cancer Research Institute". [[The New York Times]].
20. (2010). "The Emperor of All Maladies: A Biography of Cancer".
21. Bouton, Katherine. (January 29, 1989). "The Nobel Pair". The New York Times.
22. (2010). "The Immortal Life of Henrietta Lacks". Crown/Archetype.
23. (1967). "Experimentation on Human Beings.". Stanford Law Review.
24. (June 15, 1956). "14 Convicts Injected With Live Cancer Cells". The New York Times.
25. (April 15, 1957). "Cancer Defenses Found to Differ; Tests Indicate Victims Lack Some Mechanisms That Well Human Being Has Cancer Recurred Deficiency Is Noted Warning by Southam". The New York Times.
26. (January 26, 1964). "Many Scientific Experts Condemn Ethics of Cancer Injection". The New York Times.
27. (March 22, 1964). "Scientists Split on Cancer Tests". The New York Times.
28. (July 8, 1964). "Ruling is Upset on Cancer Test". The New York Times.
29. (April 19, 1960). "U.S. Aide to Head Cancer Center: Dr. John R. Heller, Cured of Disease, to Assume New Sloan-Kettering Post". The New York Times.
30. (December 3, 1972). "Parents Are on Team at Memorial's Day Hospital for Children With Cancer". The New York Times.
31. "Memorial Sloan-Kettering Cancer Center Annual Report, 1977".
32. (July 20, 1997). "Scientist at Work: Jimmie Holland; Listening to the Emotional Needs of Cancer Patients". The New York Times.
33. Barbanel, Josh. [https://www.nytimes.com/2006/09/17/realestate/17deal1.html "Would an Aardvark Live Here?"] ''[[The New York Times]]'', September 17, 2006. Retrieved December 31, 2009.
34. (2014-08-01). "G-CSF: From granulopoietic stimulant to bone marrow stem cell mobilizing agent". Cytokine & Growth Factor Reviews.
35. (1986-04-04). "Recombinant Human Granulocyte Colony-Stimulating Factor: Effects on Normal and Leukemic Myeloid Cells". Science.
36. (January 1986). "Molecular cloning and expression of cDNA for human granulocyte colony-stimulating factor". Nature.
37. (1990-11-13). "Amgen to Pay Lower Royalties on New Drug : Pharmaceuticals: It costs the Thousand Oaks firm $50 million to alter its agreement with a research center. That will lead to a loss this quarter.".
38. (March 1985). "Purification and biochemical characterization of human pluripotent hematopoietic colony-stimulating factor.". Proceedings of the National Academy of Sciences.
39. "The Harold Varmus Papers: Memorial Sloan Kettering Cancer Center, 2000-2010, and National Cancer Institute, 2010-2015".
40. "Sloan Kettering Institute: About SKI". Memorial Sloan Kettering Cancer Center.
41. (October 5, 2009). "New Evelyn H. Lauder Breast Center and MSKCC Imaging Center Opens".
42. (August 10, 2010). "Craig Thompson Named President of Memorial Sloan-Kettering Cancer Center". Memorial Sloan Kettering Cancer Center.
43. (February 10, 2011). "The role of public-sector research in the discovery of drugs and vaccines.". The New England Journal of Medicine.
44. (November 10, 2012). "Center names physician-in-chief". HemOnc Today.
45. "Memorial Sloan-Kettering Cancer Center Annual Report, 2013".
46. (November 26, 2013). "El español Joan Massagué, al frente del Sloan-Kettering de Nueva York". El Mundo.
47. (14 September 2018). "Why do medical journals keep taking authors at their word? - STAT". STAT.
48. (September 9, 2018). "MSK Cancer Center Orders Staff to 'Do a Better Job' of Disclosing Industry Ties". The New York Times.
49. "Josie Robertson Surgery Center".
50. "Sloan-Kettering Receives $50 Million From Robertson Foundation".
51. (2019-09-10). "FDA approves CAR-T cell therapy to treat adults with certain types of large B-cell lymphoma".
52. Tontonoz, Matthew. (August 30, 2017). "FDA Approves First CAR T Cell Therapy for Leukemia".
53. "How Scientists Built a 'Living Drug' to Beat Cancer".
54. (2019-10-01). "Cell Therapy Manufacturing Tries "Building the Plane While Flying It"".
55. Tontonoz, Matthew. (October 19, 2017). "FDA Approves CAR T Cell Therapy for Non-Hodgkin Lymphoma".
56. "MSK-IMPACT: A Targeted Test for Mutations in Both Rare and Common Cancers".
57. (2018-05-22). "Tisagenlecleucel (Kymriah) Approved to Treat Some Lymphomas".
58. (December 10, 2019). "A New Era of Care: The David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center to Open in January 2020".
59. (20 April 2022). "MSmall cancer drug trial sees tumors disappear in 100 percent of patients". WSJ.
60. (December 12, 2023). "Memorial Sloan Kettering Cancer Center Announces Landmark $400 Million Gift From Citadel Founder and CEO Kenneth C. Griffin and David Geffen, Founder of the David Geffen Foundation".
61. (December 1, 2025). "The Transgender Cancer Patient and What She Heard on Tape". [[The New York Times]].
62. (April 3, 2025). "Transgender Patient Sues Memorial Sloan Kettering Cancer Center for Years of Discriminatory Treatment".
63. "Memorial Sloan Kettering Cancer Center Regional Sites".
64. "History & Milestones". Memorial Sloan Kettering Cancer Center.
65. (2008). "Integrative Cancer Care in a US Academic Cancer Centre: The Memorial Sloan–Kettering Experience". Curr. Oncol..
66. (July 1, 2010). "New Facility Eases Patient Experience and Promotes Collaborative Treatment and Research".
67. (October 1, 2010). "Memorial Sloan Kettering Opens Outpatient Rehabilitation Center".
68. (2019-11-20). "Trio Of Medical Networks Join Forces To Fight Cancer With New Proton Center In Harlem".
69. "New York Proton Center {{!}} Memorial Sloan Kettering Cancer Center".
70. "New York City's largest freestanding cancer center opens".
71. (2019-12-10). "MSK to open $1.5B Koch Center for Cancer Care".
72. Herman, Gabe. (December 12, 2019). "New cancer center opens next month on Upper East Side".
73. (February 13, 2017). "Construction Update: Koch Center for Cancer Care".
74. (2022-08-27). "Memorial Sloan Kettering Cancer Center inaugurates centre in Chennai". The Hindu.
75. "Memorial Sloan-Kettering Cancer Center Annual Report, 2005".
76. (May 18, 2012). "First Four Students Receive Doctoral Degrees from Louis V. Gerstner, Jr. Graduate School of Biomedical Sciences". Memorial Sloan Kettering Cancer Center.
77. (October 19, 2018). "MSK's Graduate School Welcomes New Dean, Bids Farewell to Its First". Memorial Sloan Kettering Cancer Center.
78. "Graduate School of Medical Sciences {{!}} Weill Cornell Medicine".
79. "Office of the President: Past Presidents {{!}} Memorial Sloan Kettering Cancer Center".
80. "Charity Ratings".